Literature DB >> 16899784

A proposal for radical changes in the drug-approval process.

Alastair J J Wood1.   

Abstract

Mesh:

Year:  2006        PMID: 16899784     DOI: 10.1056/NEJMsb055203

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  25 in total

1.  New approaches to rewarding pharmaceutical innovation.

Authors:  Paul Grootendorst; Aidan Hollis; David K Levine; Thomas Pogge; Aled M Edwards
Journal:  CMAJ       Date:  2010-12-13       Impact factor: 8.262

2.  Food and Drug Administration.

Authors:  Linda R Horton
Journal:  BMJ       Date:  2007-01-13

Review 3.  Economic evaluations in the canadian common drug review.

Authors:  Andreas Laupacis
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

4.  Drug discovery in jeopardy.

Authors:  Pedro Cuatrecasas
Journal:  J Clin Invest       Date:  2006-11       Impact factor: 14.808

Review 5.  How can we regulate medicines better?

Authors:  Silvio Garattini; Vittorio Bertele'
Journal:  BMJ       Date:  2007-10-20

Review 6.  Gap in publication of comparative information on new medicines.

Authors:  Johan C F van Luijn; Pieter Stolk; Frank W J Gribnau; Hubert G M Leufkens
Journal:  Br J Clin Pharmacol       Date:  2008-02-21       Impact factor: 4.335

7.  Response to AMA's Council on Ethical and Judicial Affairs draft report on "Ethical guidance for physicians and the profession with respect to industry support for professional education in medicine".

Authors:  Thomas P Stossel
Journal:  Medscape J Med       Date:  2008-06-12

8.  Polypharmacy, inappropriate prescribing and adverse drug reactions in Austria.

Authors:  Markus Müller
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

9.  Off-licence prescribing and regulation in psychiatry: current challenges require a new model of governance.

Authors:  Philip Sugarman; Amy Mitchell; Catherine Frogley; Geoffrey L Dickens; Marco Picchioni
Journal:  Ther Adv Psychopharmacol       Date:  2013-08

10.  Risk assessment and communication tools for genotype associations with multifactorial phenotypes: the concept of "edge effect" and cultivating an ethical bridge between omics innovations and society.

Authors:  Vural Ozdemir; Guilherme Suarez-Kurtz; Raphaëlle Stenne; Andrew A Somogyi; Toshiyuki Someya; S Oğuz Kayaalp; Eugene Kolker
Journal:  OMICS       Date:  2009-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.